1.56
price down icon2.50%   -0.04
after-market 시간 외 거래: 1.57 0.01 +0.64%
loading
전일 마감가:
$1.60
열려 있는:
$1.64
하루 거래량:
14,676
Relative Volume:
0.41
시가총액:
$25.29M
수익:
-
순이익/손실:
$-13.59M
주가수익비율:
-1.4444
EPS:
-1.08
순현금흐름:
$-19.79M
1주 성능:
-5.45%
1개월 성능:
-8.77%
6개월 성능:
-55.93%
1년 성능:
-63.29%
1일 변동 폭
Value
$1.5472
$1.85
1주일 범위
Value
$1.42
$1.85
52주 변동 폭
Value
$1.42
$5.97

Calcimedica Inc Stock (CALC) Company Profile

Name
명칭
Calcimedica Inc
Name
전화
858-952-5500
Name
주소
505 COAST BOULEVARD SOUTH, LA JOLLA
Name
직원
15
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
CALC's Discussions on Twitter

CALC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CALC
Calcimedica Inc
1.56 25.29M 0 -13.59M -19.79M -1.08
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Calcimedica Inc 주식(CALC)의 최신 뉴스

pulisher
Jun 13, 2025

CalciMedica Insiders Added US$1.05m Of Stock To Their Holdings - Yahoo Finance

Jun 13, 2025
pulisher
Jun 12, 2025

CalciMedica's Breakthrough AKI Treatment Takes Center Stage at Prestigious Vicenza Nephrology Conference - Stock Titan

Jun 12, 2025
pulisher
Jun 12, 2025

Millennium Management LLC Acquires 16,824 Shares of CalciMedica, Inc. (NASDAQ:CALC) - Defense World

Jun 12, 2025
pulisher
Jun 06, 2025

calcimedica appoints baker tilly as new accounting firm after merger By Investing.com - Investing.com South Africa

Jun 06, 2025
pulisher
Jun 06, 2025

calcimedica appoints baker tilly as new accounting firm after merger - Investing.com

Jun 06, 2025
pulisher
May 17, 2025

HC Wainwright Reiterates “Buy” Rating for CalciMedica (NASDAQ:CALC) - Defense World

May 17, 2025
pulisher
May 15, 2025

CalciMedica (CALC) Receives Reiteration of Buy Rating with $16 P - GuruFocus

May 15, 2025
pulisher
May 14, 2025

CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates - Citizen Tribune

May 14, 2025
pulisher
May 10, 2025

CalciMedica (CALC) Expected to Announce Quarterly Earnings on Monday - Defense World

May 10, 2025
pulisher
May 09, 2025

CalciMedica Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView

May 09, 2025
pulisher
May 07, 2025

Renaissance Technologies LLC Purchases New Stake in CalciMedica, Inc. (NASDAQ:CALC) - Defense World

May 07, 2025
pulisher
May 04, 2025

Geode Capital Management LLC Boosts Stock Holdings in CalciMedica, Inc. (NASDAQ:CALC) - Defense World

May 04, 2025
pulisher
Apr 28, 2025

Bristol-Myers Squibb (NYSE:BMY) vs. CalciMedica (NASDAQ:CALC) Critical Review - Defense World

Apr 28, 2025
pulisher
Apr 24, 2025

CalciMedica (NASDAQ:CALC) Shares Up 0.7% – Here’s Why - Defense World

Apr 24, 2025
pulisher
Apr 17, 2025

CalciMedica's Breakthrough Research Takes Center Stage at Two Elite Medical Conferences - Stock Titan

Apr 17, 2025
pulisher
Apr 17, 2025

CalciMedica Announces Presentations at Upcoming Medical Meetings - PR Newswire

Apr 17, 2025
pulisher
Apr 03, 2025

Analysts Offer Predictions for CalciMedica Q4 Earnings - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

CalciMedica Inc. (CALC) Moves to Buy: Rationale Behind the Upgrade - Yahoo Finance

Apr 02, 2025
pulisher
Apr 02, 2025

Corient Private Wealth LLC Buys New Shares in CalciMedica, Inc. (NASDAQ:CALC) - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

CalciMedica (NASDAQ:CALC) Receives “Buy” Rating from HC Wainwright - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Corient Private Wealth LLC Acquires Shares of 38,000 CalciMedica, Inc. (NASDAQ:CALC) - The AM Reporter

Apr 02, 2025
pulisher
Apr 01, 2025

Graybug Vision stock hits 52-week low at $1.81 - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

Graybug Vision stock hits 52-week low at $1.81 By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

H.C. Wainwright maintains $16 target on CalciMedica stock - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

CalciMedica’s Strong Financial Position and Promising Clinical Pipeline Justify Buy Rating - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference - PR Newswire

Apr 01, 2025
pulisher
Mar 27, 2025

CalciMedica says cash sufficient to fund operating plan into mid-2026 - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

CALCIMEDICA Earnings Results: $CALC Reports Quarterly Earnings - Nasdaq

Mar 27, 2025
pulisher
Mar 27, 2025

CalciMedica Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025
pulisher
Mar 27, 2025

CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates - Citizen Tribune

Mar 27, 2025
pulisher
Mar 27, 2025

Calcimedica Reports 2024 Financial Results And Provides Clinical & Corporate Updates - MarketScreener

Mar 27, 2025
pulisher
Mar 25, 2025

CalciMedica (CALC) to Release Earnings on Thursday - The AM Reporter

Mar 25, 2025
pulisher
Mar 24, 2025

CalciMedica Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView

Mar 24, 2025
pulisher
Mar 20, 2025

Atria Investments Inc Buys 7,509 Shares of CalciMedica, Inc. (NASDAQ:CALC) - Defense World

Mar 20, 2025
pulisher
Mar 20, 2025

CalciMedica (CALC) Expected to Announce Quarterly Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 13, 2025

Graybug Vision stock hits 52-week low at $1.83 amid challenges - Investing.com

Mar 13, 2025
pulisher
Mar 11, 2025

Rani Therapeutics (NASDAQ:RANI) versus CalciMedica (NASDAQ:CALC) Financial Contrast - Defense World

Mar 11, 2025
pulisher
Mar 07, 2025

Promising Phase 2 Results and Market Potential Drive Buy Rating for CalciMedica’s Auxora - TipRanks

Mar 07, 2025
pulisher
Mar 06, 2025

Short Interest in CalciMedica, Inc. (NASDAQ:CALC) Increases By 35.0% - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Latham & Watkins Advises CalciMedica in Secured Growth Financing - Latham & Watkins LLP

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica secures $32.5 million credit facility By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica secures credit facility for up to $32.5M - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica Secures Credit Facility For Up To $32.5 Million -March 05, 2025 at 07:44 am EST - Marketscreener.com

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica secures $32.5 million credit facility - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica Secures Credit Facility for Up to $32.5 Million - Finansavisen

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica (NASDAQ:CALC) Given “Buy” Rating at HC Wainwright - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Graybug Vision stock hits 52-week low at $1.95 amid challenges - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica reports reduced mortality in AKI trial with Auxora - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica Highlights Auxora’s Potential in COVID-19 Treatment - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica reports reduced mortality in AKI trial with Auxora By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica’s Auxora shows mortality reduction in COVID-19 pneumonia trial - TipRanks

Mar 04, 2025

Calcimedica Inc (CALC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Calcimedica Inc 주식 (CALC) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Bardin Stephen
Chief Financial Officer
Jun 26 '25
Buy
1.50
2,000
3,005
3,000
Roberts Eric W
CHIEF BUSINESS OFFICER
Jun 11 '25
Buy
1.85
5,000
9,250
28,323
Roberts Eric W
CHIEF BUSINESS OFFICER
Jun 06 '25
Buy
1.77
5,000
8,875
23,323
Roberts Eric W
CHIEF BUSINESS OFFICER
Jun 05 '25
Buy
1.70
5,100
8,670
18,323
Bardin Stephen
Chief Financial Officer
May 30 '25
Buy
1.69
1,000
1,690
41,000
MIDDLETON FRED A
Director
Dec 06 '24
Buy
2.65
4,800
12,720
36,514
Sanderling Venture Partners VI
10% Owner
Nov 01 '24
Buy
3.75
86,867
325,751
814,300
Sanderling Venture Partners VI
10% Owner
Nov 01 '24
Buy
3.75
877
3,289
22,479
MIDDLETON FRED A
Director
Nov 01 '24
Buy
3.75
87,744
329,040
814,300
MIDDLETON FRED A
Director
Nov 01 '24
Buy
3.75
20,000
75,000
31,714
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):